{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T16:46:59Z","timestamp":1751215619435},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.radonc.2018.10.014","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T13:21:04Z","timestamp":1540905664000},"page":"139-148","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Are hypothyroidism and hypogonadism clinically relevant in patients with malignant gliomas? A longitudinal trial in patients with glioma"],"prefix":"10.1016","volume":"130","author":[{"given":"Ammon","family":"Handisurya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Rumpold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Caucig-L\u00fctgendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Flechl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayseg\u00fcl","family":"Ilhan-Mutlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Dieckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Widhalm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Grisold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelheid","family":"W\u00f6hrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Hainfellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Ristl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Marosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alois","family":"Gessl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Hassler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.10.014_b0005","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jon.12181","article-title":"Histologically Proven radiation-induced brainstem glioma 93 months after external beam radiotherapy for pituitary macroadenoma: radiation treatment dose and volume correlation","volume":"25","author":"Abboud","year":"2015","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.radonc.2018.10.014_b0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1006471405435","article-title":"Endocrine dysfunctions in patients treated for brain tumors: incidence and guidelines for management","volume":"47","author":"Brandes","year":"2000","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0015","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/neuonc\/nou304","article-title":"Medical management of brain tumors and the sequelae of treatment","volume":"17","author":"Schiff","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clon.2016.09.012","article-title":"Time dependence of radiation-induced hypothalamic-pituitary axis dysfunction in adults treated for non-pituitary, intracranial neoplasms","volume":"29","author":"Taku","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2018.10.014_b0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01057753","article-title":"Endocrine functions in long-term survivors of low-grade supratentorial glioma treated with radiation therapy","volume":"25","author":"Taphoorn","year":"1995","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ncpendmet1051","article-title":"Radiation-induced hypopituitarism after cancer therapy: who, how and when to test","volume":"5","author":"Darzy","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.radonc.2018.10.014_b0035","first-page":"1","article-title":"Radiation-induced growth hormone deficiency","volume":"59","author":"Darzy","year":"2003","journal-title":"Horm Res"},{"issue":"Suppl A","key":"10.1016\/j.radonc.2018.10.014_b0040","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ghir.2006.03.002","article-title":"Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement","volume":"16","author":"Darzy","year":"2006","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.radonc.2018.10.014_b0045","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.ijrobp.2007.08.015","article-title":"Reirradiation tolerance of the human brain","volume":"70","author":"Mayer","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.014_b0050","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2002-021994","article-title":"Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor","volume":"88","author":"Schmiegelow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.radonc.2018.10.014_b0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1210\/jc.2002-020380","article-title":"A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor","volume":"88","author":"Schmiegelow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.radonc.2018.10.014_b0060","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0022-3476(80)80254-X","article-title":"Endocrine and neurologic outcome in childhood craniopharyngioma: review of effect of treatment in 42 patients","volume":"97","author":"Thomsett","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.radonc.2018.10.014_b0065","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2265.1989.tb01260.x","article-title":"Radiation-induced hypopituitarism is dose-dependent","volume":"31","author":"Littley","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.radonc.2018.10.014_b0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cen.12815","article-title":"Endocrine sequelae beyond 10 years in survivors of medulloblastoma","volume":"83","author":"Uday","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.radonc.2018.10.014_b0075","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1210\/jc.2005-1525","article-title":"Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults","volume":"90","author":"Agha","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.radonc.2018.10.014_b0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.radonc.2011.02.015","article-title":"Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors","volume":"99","author":"Madaschi","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0085","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0090","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2018.10.014_b0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2010.08.020","article-title":"Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide","volume":"97","author":"Minniti","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0100","unstructured":"International Commission of Radiation Units and Measurements. Prescribing, Recording and Reporting Photon Beam Therapy. ICRU Report 50, ICRU, Bethesda, MD; 1993."},{"key":"10.1016\/j.radonc.2018.10.014_b0105","unstructured":"International Commission of Radiation Units and Measurements. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU report 50). ICRU Report 62, ICRU, Bethesda, MD; 1999."},{"key":"10.1016\/j.radonc.2018.10.014_b0110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S2213-8587(15)00008-X","article-title":"Effect of cancer treatment on hypothalamic-pituitary function","volume":"3","author":"Crowne","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.radonc.2018.10.014_b0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-14-0845","article-title":"Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma","volume":"172","author":"Albarel","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.radonc.2018.10.014_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-09-0412","article-title":"Mechanisms behind the non-thyroidal illness syndrome: an update","volume":"205","author":"Warner","year":"2010","journal-title":"J Endocrinol"},{"key":"10.1016\/j.radonc.2018.10.014_b0125","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s10072-015-2111-7","article-title":"Occurrence and predictors of the fatigue in high-grade glioma patients","volume":"36","author":"Aprile","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.radonc.2018.10.014_b0130","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/neuonc\/not102","article-title":"The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial","volume":"15","author":"Boele","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11060-011-0723-1","article-title":"A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor","volume":"107","author":"Gehring","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11060-008-9738-7","article-title":"Fatigue in low-grade glioma","volume":"92","author":"Struik","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11060-014-1574-3","article-title":"Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients","volume":"120","author":"Peters","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0150","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2008.13.5293","article-title":"Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial","volume":"26","author":"Laughton","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0155","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.2006.08.4772","article-title":"Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease","volume":"25","author":"Donaldson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0160","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1200\/JCO.1987.5.11.1841","article-title":"Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies","volume":"5","author":"Constine","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0165","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/ijc.23277","article-title":"Hypothyroidism among pediatric cancer patients: a nationwide, registry-based study","volume":"122","author":"Madanat","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2018.10.014_b0170","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s11764-015-0439-x","article-title":"Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region","volume":"9","author":"Seland","year":"2015","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.radonc.2018.10.014_b0175","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/cncr.24808","article-title":"Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma","volume":"116","author":"Jones","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2018.10.014_b0180","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1634\/theoncologist.2009-0265","article-title":"Changes in functional performance measures in adults undergoing chemoradiation for primary malignant glioma: a feasibility study","volume":"15","author":"Jones","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.radonc.2018.10.014_b0185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00508-012-0186-1","article-title":"Strength of skeletal muscle and self-reported physical performance in Austrian glioblastoma-patients","volume":"124","author":"Keilani","year":"2012","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.radonc.2018.10.014_b0190","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1200\/JCO.2011.34.9852","article-title":"Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma","volume":"29","author":"Ruden","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0195","first-page":"40","article-title":"Fertility preservation in primary brain tumor patients","volume":"4","author":"Jacqueline","year":"2016","journal-title":"Neuro Oncology Practice"},{"key":"10.1016\/j.radonc.2018.10.014_b0200","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1200\/JCO.2015.64.5168","article-title":"Cancer and fertility program improves patient satisfaction with information received","volume":"34","author":"Kelvin","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.014_b0205","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.maturitas.2015.07.019","article-title":"Menopause prediction and potential implications","volume":"82","author":"Daan","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.radonc.2018.10.014_b0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0378-5122(99)00075-4","article-title":"Andropause","volume":"34","author":"Vermeulen","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.radonc.2018.10.014_b0215","first-page":"203","article-title":"Epidemiology of the symptoms of menopause \u2013 An intercontinental review","volume":"13","author":"Makara-Studzinska","year":"2014","journal-title":"Prz Menopauzalny"},{"key":"10.1016\/j.radonc.2018.10.014_b0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1025573529407","article-title":"A review of symptoms commonly associated with menopause: implications for clinical neuropsychologists and other health care providers","volume":"13","author":"O'Bryant","year":"2003","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.radonc.2018.10.014_b0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1477-7525-3-47","article-title":"Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review","volume":"3","author":"Utian","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.radonc.2018.10.014_b0230","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/jsm.12404","article-title":"Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study","volume":"11","author":"Hackett","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.radonc.2018.10.014_b0235","first-page":"729","article-title":"Patients with testosterone deficit syndrome and depression","volume":"66","author":"Khera","year":"2013","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.radonc.2018.10.014_b0240","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4330\/wjc.v7.i9.504","article-title":"Central and peripheral testosterone effects in men with heart failure: an approach for cardiovascular research","volume":"7","author":"Busic","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.radonc.2018.10.014_b0245","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrendo.2016.45","article-title":"Late endocrine effects of childhood cancer","volume":"12","author":"Rose","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.radonc.2018.10.014_b0250","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/299551a0","article-title":"Prolactin and parental behaviour in a male New World primate","volume":"299","author":"Dixson","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2018.10.014_b0255","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0003-3472(63)90256-2","article-title":"Prolactin or progesterone as key to parental behaviour: a review","volume":"11","author":"Riddle","year":"1963","journal-title":"Anim Behav"},{"key":"10.1016\/j.radonc.2018.10.014_b0260","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0003-3472(67)90021-8","article-title":"The effects of prolactin and testosterone on the parental behaviour of the male stickleback Gasterosteus aculeatus","volume":"15","author":"Smith","year":"1967","journal-title":"Anim Behav"},{"key":"10.1016\/j.radonc.2018.10.014_b0265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpsychires.2014.10.011","article-title":"Stress biomarkers as predictors of transition to psychosis in at-risk mental states: roles for cortisol, prolactin and albumin","volume":"60","author":"Labad","year":"2015","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.radonc.2018.10.014_b0270","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.scitotenv.2014.10.008","article-title":"Corticosterone, prolactin and egg neglect behavior in relation to mercury and legacy POPs in a long-lived Antarctic bird","volume":"505","author":"Tartu","year":"2015","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.radonc.2018.10.014_b0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13058-015-0563-6","article-title":"Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study","volume":"17","author":"Tikk","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.radonc.2018.10.014_b0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1158\/1055-9965.EPI-14-0896","article-title":"Bioactive prolactin levels and risk of breast cancer: a nested case-control study","volume":"24","author":"Tworoger","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018335382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018335382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T22:03:39Z","timestamp":1548540219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814018335382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":56,"alternative-id":["S0167814018335382"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.10.014","relation":{},"ISSN":["0167-8140"],"issn-type":[{"type":"print","value":"0167-8140"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are hypothyroidism and hypogonadism clinically relevant in patients with malignant gliomas? A longitudinal trial in patients with glioma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}